New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 13, 2012
15:01 EDTPRGO, CPIXPerrigo confirms settlement of generic version of Acetadote patent litigation
Perrigo (TASE) announced that it has agreed to settle its Hatch-Waxman litigation relating to Acetadote injection brought by Cumberland Pharmaceuticals (CPIX). Under the terms of the settlement, Perrigo can launch a generic version of Acetadote injection upon expiration of the patents in May 2026. In addition, Perrigo entered into an agreement with Cumberland wherein Perrigo can distribute Cumberland sourced authorized generic product upon generic market formation. Acetadote injection, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury and has annual sales of approximately $41M, as measured by Wolters Kluwer. Perrigo's Chairman and CEO Joseph C. Papa stated, "This settlement is another example of our long-term investment in extended product development. As always, Perrigo is committed to making quality healthcare more affordable for our customers."
News For PRGO;CPIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
09:39 EDTPRGOPerrigo in exclusive talks to buy Omega Pharma, Bloomberg says
Subscribe for More Information
09:18 EDTPRGOPerrigo in exclusive talks to buy Omega Pharma, Bloomberg says
Subscribe for More Information
October 21, 2014
06:44 EDTPRGOActavis among bidders for Omega Pharma, Bloomberg reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use